During the past decade, Dickstein Cancer Treatment Center at White Plains Hospital Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 8 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dickstein Cancer Treatment Center at White Plains Hospital Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 2 trials, followed by "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored, "Amgen" with 1 trials sponsored, "Camurus AB" with 1 trials sponsored and "Eastern Cooperative Oncology Group" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dickstein Cancer Treatment Center at White Plains Hospital Center" #1 collaborator was "National Cancer Institute (NCI)" with 8 trials as a collaborator, "Cancer and Leukemia Group B" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Novartis" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Dickstein Cancer Treatment Center at White Plains Hospital Center" are "Breast Cancer" (3 trials), "Pain" (2 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (2 trials), "Acute Myeloid Leukemia" (1 trials) and "Breast Adenocarcinoma" (1 trials). Many other conditions were trialed in "Dickstein Cancer Treatment Center at White Plains Hospital Center" in a lesser frequency.

Most popular intervention types in "Dickstein Cancer Treatment Center at White Plains Hospital Center" are "Drug" (11 trials), "Other" (3 trials), "Biological" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (2 trials), "Azacitidine" (1 trials), "Bavituximab" (1 trials), "Bevacizumab" (1 trials) and "CAM2029" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dickstein Cancer Treatment Center at White Plains Hospital Center" are 10 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Dickstein Cancer Treatment Center at White Plains Hospital Center". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Dickstein Cancer Treatment Center at White Plains Hospital Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dickstein Cancer Treatment Center at White Plains Hospital Center, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".